Mercy Hospital & Health Services Contact Us
MyChart
About Mercy
Join Our Team
set font size large set font size medium set font size small
email this page print this page
SureScan Banner

SureScan Post-Approval Study

Sponsored by Medtronic Cardiac Rhythm Disease Management


The purpose of this Post-Approval Study (PAS) is to demonstrate the chronic performance of the SureScan pacing system when used in an MRI environment according to product labeling. This study is required by the Food and Drug Administration (FDA) as a condition of product approval. This study is part of the Product Performance Platform (PPP).

Condition
Bradycardia

 
Groups/Chohorts
Chronic Performance Arm
Subjects enrolled prior to or within 30 days post implant of SureScan pacing system. In office follow-up visits required every 6 months
Multiple MRI Scan Arm
Subject enrolled into study at the time of MRI Scan indication. Subject followed per clinic's standard of care.

separator

Eligibility


Genders Eligible for Study:Both
Accepts Healthy Volunteers:No
Sampling Method:Non-Probability Sample

Study Population
Patients indicated for or implanted with a Medtronic SureScan Pacing System. All subjects must meet Inclusion criteria and none of the Exclusion criteria.

Criteria

Inclusion Criteria:
  1. Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
  2. Subject is or intended to be implanted with a complete SureScan pacing system consisting of both a right atrial and ventricular 5086MRI Lead (used for pacing and sensing) and a SureScan device
  3. Subject within 30 days of implant (maximum 50% of Chronic Performance Arm enrollment) or subject enrolled into Multiple MRI Scan Arm at the time of MRI scan indication
Exclusion Criteria:
  1. Subject who is, or will be inaccessible for follow-up
  2. Implant and follow-up data, including adverse device effects and system modifications at implant through the time of enrollment are unavailable
  3. Subject with exclusion criteria required by local law
separator

Contacts and Locations


Contacts
Physicians:

Ameer Kabour, MD

Coordinators:
Brenda Hoagland, RN, CCRC
Michelle Hickam, BSN
Julie Neidhardt, BSN

Please contact us at 419-251-4919 for more information about this study.
www.mercyweb.org
follow us online
facebook youtube


Contact us
Home  |  Sitemap

Disclaimer & Terms of Use  |  Privacy Statement  |  Notice of Privacy Practices
Copyright ©2013 Mercy. Last modified 10/14/2011